CytomX Therapeutics, Inc. - CTMX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners III, L.P. | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Co-Investment Holdings III, LLC | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | Venrock Healthcare Capital Partners EG, L.P. | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management III, LLC | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | VHCP Management EG, LLC | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | Nimish Shah | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | Bong Y. Koh | 4.6% | 9,982,124 | View |
| May 15, 2026 | SCHEDULE 13G/A | Seven Fleet Master Fund LP | 0.5% | 1,085,398 | View |
| May 15, 2026 | SCHEDULE 13G/A | Seven Fleet Capital Management LP | 0.5% | 1,085,398 | View |
| May 15, 2026 | SCHEDULE 13G/A | Seven Fleet Capital Management GP LLC | 0.5% | 1,085,398 | View |
| May 15, 2026 | SCHEDULE 13G/A | Brian Liu | 0.5% | 1,085,398 | View |
| May 15, 2026 | SCHEDULE 13G/A | Longitude Capital Partners V, LLC | 5.7% | 12,458,461 | View |
| May 15, 2026 | SCHEDULE 13G/A | Longitude Venture Partners V, L.P. | 5.7% | 12,458,461 | View |
| May 15, 2026 | SCHEDULE 13G/A | Longitude 103.8 East Partners, LLC | 1.3% | 2,830,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Longitude 103.8 East, L.P. | 1.3% | 2,830,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Patrick G. Enright | 7.0% | 15,288,461 | View |
| May 15, 2026 | SCHEDULE 13G/A | Juliet Tammenoms Bakker | 7.0% | 15,288,461 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 4.6% | 10,098,824 | View |
| May 15, 2026 | SCHEDULE 13G/A | Joseph Edelman | 4.6% | 10,098,824 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 4.6% | 10,098,824 | View |
| May 15, 2026 | SCHEDULE 13G/A | Kynam Capital Management, LP | 6.9% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Kynam Capital Management GP, LLC | 6.9% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | Yue Tang | 6.9% | 0 | View |
| Apr 16, 2026 | SCHEDULE 13G | Point72 Asset Management, L.P. | 5.0% | 10,864,581 | View |
| Apr 16, 2026 | SCHEDULE 13G | Point72 Capital Advisors, Inc. | 5.0% | 10,864,581 | View |
| Apr 16, 2026 | SCHEDULE 13G | Steven A. Cohen | 5.0% | 10,864,581 | View |
| Mar 26, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Mar 04, 2026 | SCHEDULE 13G | Kynam Capital Management, LP | 5.29% | 8,966,077 | View |
| Mar 04, 2026 | SCHEDULE 13G | Kynam Capital Management GP, LLC | 5.29% | 8,966,077 | View |
| Mar 04, 2026 | SCHEDULE 13G | Yue Tang | 5.29% | 8,966,077 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | OrbiMed Advisors LLC | 2.1% | 3,525,650 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | KEVIN TANG | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 14.6% | 24,688,109 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 14.6% | 24,688,109 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.